Enteralia Bioscience completed the acquisition of TFarma.

Enteralia Bioscience, an Italian pharmaceutical company, completed the acquisition of TFarma, a well-established company specializing in the sales and marketing of nutraceuticals and medical devices in Italy. Financial terms were not disclosed. "We are delighted to welcome TFarma and its team into the Enteralia family, accelerating our future growth and strengthening our position in the Italian market. The synergy between our product lines and the experience of TFarma’s team reinforces our strategy and ability to accomplish increasingly ambitious growth," Antonio Maggi, Enteralia CEO.